Elevation Oncology Inc.
0.73
-0.05 (-6.46%)
At close: Jan 15, 2025, 10:29 AM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue n/a n/a n/a n/a n/a
Cost of Revenue 39.00K 27.00K 18.00K 15.00K n/a
Gross Profit -39.00K -27.00K -18.00K -15.00K n/a
Operating Income -45.45M -94.55M -32.05M -17.28M -5.88M
Interest Income 3.90M n/a n/a n/a n/a
Pretax Income -45.67M -95.06M -32.04M -17.27M -5.88M
Net Income -45.70M -95.08M -32.04M -17.27M -5.88M
Selling & General & Admin 14.90M 15.83M 8.45M 1.80M 544.00K
Research & Development 25.43M 78.72M 23.59M 15.48M 5.34M
Other Expenses 5.11M -506.00K 7.00K 11.00K n/a
Operating Expenses 45.45M 94.55M 32.05M 17.28M 5.88M
Interest Expense 4.17M 479.00K n/a n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a 543.18K
Cost & Expenses 45.45M 94.55M 32.05M 17.28M 5.88M
Income Tax 30.00K 25.00K -218.56K -191.30K -8.82K
Shares Outstanding (Basic) 34.08M 23.27M 23.21M 23.76M 23.76M
Shares Outstanding (Diluted) 34.08M 23.27M 23.21M 23.76M 23.76M
EPS (Basic) -1.34 -4.09 -1.38 -0.73 -0.25
EPS (Diluted) -1.34 -4.09 -1.38 -0.73 -0.25
EBITDA -41.47M -94.52M -32.03M -17.25M -5.88M
Depreciation & Amortization 39.00K 27.00K 18.00K 15.00K 3.57M